Devi SenGupta, MD

Sr Director, Clinical Research (MD)
Gilead Sciences Inc.

Disclosure: Gilead Sciences Inc. (Individual(s) Involved: Self): Employee, Shareholder

Presentation(s):

• 72 - Remdesivir vs Standard Care in Patients with Moderate covid-19

  Oral Abstract

• 73 - Geographical Disparities in Clinical Outcomes of Severe COVID-19 Patients Treated with Remdesivir

  Oral Abstract